Two sides of the warfarin issue: Diligence versus potency [5]

American Journal of Medicine

Volumn 110, Issue 8, 2001, Pages 672-674

  Rothschild, Bruce M ^a   Helbling Ii, Mark E ^a  

^a ARTHRITIS CENTER OF NORTHEAST OHIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYCHLOROQUINE; ISOSORBIDE; METOPROLOL; WARFARIN;

ANTICOAGULANT THERAPY; AVASCULAR NECROSIS; DRUG POTENCY; HEART INFARCTION; HUMAN; LETTER; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS; TABLET FORMULATION;

ADULT; ANTICOAGULANTS; FEMALE; HUMANS; INTERNATIONAL NORMALIZED RATIO; WARFARIN;

EID: 0035368525     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9343(01)00712-4     Document Type: Letter

References (4)

1. Management and dosing of warfarin therapy
2. Oral anticoagulation management in primary care with use of computerized decision support and near-patient testing
3. The challenge of postal medicine
4. The "lupus" circulating anticoagulant, aka the primary antiphospholipid syndrome